scPharmaceuticals
About:
ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.
Website: http://www.scpharmaceuticals.com/
Twitter/X: scPharmaUSA
Top Investors: Silicon Valley Bank, OrbiMed, Perceptive Advisors, 5AM Ventures, Lundbeckfonden Ventures
Description:
ScPharmaceticals is creating innovative and important new therapeutic options by administering drugs subcutaneously using a convenient two-component delivery system suitable for patient self-administration. In February 2013 scPharmaceuticals was formed to continue the groundbreaking work of SpringLeaf Therapeutics, a Boston area company that started in 2007. scPharmaceuticals targets the untapped opportunity of treating patients with serious medical conditions with a convenient safe and comfortable subcutaneous administration of a drug. This is therapeutically equivalent to intravenous administration while avoiding the cost, burden, and risks associated with intravenous administration.
$457M
$10M to $50M
Lexington, Massachusetts, United States
2014-01-01
info(AT)scpharma.com
Pieter Muntendam
11-50
2024-08-12
Public
© 2025 bioDAO.ai